Table 1.
Exposure/mediator | Outcome | Method | OR (95% CI) | P | Q statistic* | P h | Egger intercept | P intercept |
---|---|---|---|---|---|---|---|---|
SGLT2 inhibition | T2D | IVW | 0.25 (0.12, 0.54) | 0.0004 | 3.250 | 0.661 | ||
MR-Egger | 0.62 (0.04, 9.63) | 0.732 | 2.530 | 0.639 | 0.012 | 0.500 | ||
MR-PRESSO | 0.22 (0.12, 0.39) | 0.003 | 4.959 | 0.698 | ||||
CAD | IVW | 0.51 (0.28, 0.94) | 0.031 | 3.487 | 0.625 | |||
MR-Egger | 0.19 (0.02, 2.18) | 0.181 | 2.049 | 0.727 | −0.014 | 0.391 | ||
MR-PRESSO | 0.51 (0.38, 0.68) | 0.006 | 1.904 | 0.923 | ||||
Total choline | T2D | IVW | 0.78 (0.68, 0.89) | 0.0006 | 259.773 | 9.41 × 10−30 | ||
MR-Egger | 0.91 (0.70, 1.18) | 0.498 | 249.715 | 2.44 × 10−28 | −0.010 | 0.162 | ||
Weighted median | 0.88 (0.79, 0.98) | 0.021 | ||||||
Simple mode | 0.81 (0.65, 1.01) | 0.066 | ||||||
Weighted mode | 0.91 (0.83, 1.00) | 0.058 | ||||||
MR-PRESSO | 0.82 (0.74, 0.90) | 0.0003 | 286.130 | <0.0001 | ||||
CAD | IVW | 1.12 (0.95, 1.31) | 0.212 | 642.922 | 1.40 × 10−99 | |||
MR-Egger | 0.95 (0.70, 1.30) | 0.769 | 628.440 | 3.10 × 10−97 | 0.010 | 0.257 | ||
Weighted median | 1.12 (1.02, 1.23) | 0.018 | ||||||
Simple mode | 1.10 (0.90, 1.35) | 0.365 | ||||||
Weighted mode | 1.08 (0.98, 1.19) | 0.114 | ||||||
MR-PRESSO | 1.10 (1.01, 1.20) | 0.311 | 661.626 | <0.0001 | ||||
Phosphatidylcholine | T2D | IVW | 0.81 (0.72, 0.91) | 0.0009 | 233.996 | 1.37 × 10−24 | ||
MR-Egger | 0.90 (0.73, 1.12) | 0.357 | 227.538 | 8.07 × 10−24 | −0.008 | 0.230 | ||
Weighted median | 0.89 (0.81, 0.99) | 0.026 | ||||||
Simple mode | 0.88 (0.72, 1.06) | 0.177 | ||||||
Weighted mode | 0.91 (0.83, 0.99) | 0.028 | ||||||
MR-PRESSO | 0.84 (0.77, 0.93) | 0.001 | 246.155 | <0.0001 | ||||
CAD | IVW | 1.08 (0.94, 1.24) | 0.270 | 491.466 | 6.84 × 10−71 | |||
MR-Egger | 0.98 (0.77, 1.25) | 0.870 | 483.221 | 8.98 × 10−70 | 0.007 | 0.337 | ||
Weighted median | 1.10 (1.01, 1.20) | 0.036 | ||||||
Simple mode | 1.11 (0.91, 1.36) | 0.317 | ||||||
Weighted mode | 1.09 (1.00, 1.19) | 0.049 | ||||||
MR-PRESSO | 1.10 (1.02, 1.18) | 0.020 | 506.247 | <0.0001 | ||||
Glycine | T2D | IVW | 0.93 (0.86, 1.01) | 0.137 | 245.898 | 1.23 × 10−30 | ||
MR-Egger | 1.00 (0.91, 1.10) | 0.988 | 211.364 | 8.42 × 10−25 | −0.013 | 0.013 | ||
Weighted median | 0.96 (0.93, 1.00) | 0.067 | ||||||
Simple mode | 0.80 (0.63, 1.02) | 0.073 | ||||||
Weighted mode | 0.96 (0.92, 1.00) | 0.072 | ||||||
MR-PRESSO | 0.85 (0.75, 0.97) | 0.023 | 348.477 | <0.0001 | ||||
CAD | IVW | 0.94 (0.91, 0.98) | 0.008 | 100.528 | 1.05 × 10−6 | |||
MR-Egger | 0.97 (0.93, 1.03) | 0.326 | 85.529 | 5.65 × 10−5 | −0.007 | 0.011 | ||
Weighted median | 0.96 (0.93, 0.99) | 0.013 | ||||||
Simple mode | 0.90 (0.79, 1.03) | 0.151 | ||||||
Weighted mode | 0.95 (0.92, 0.99) | 0.008 | ||||||
MR-PRESSO | 0.88 (0.81, 0.96) | 0.006 | 226.771 | 0.015 |
OR, 95% CI, and P values were for the respective MR analysis. Ph, P value for heterogeneity; Pintercept, P value for intercept of MR-Egger regression.
Heterogeneity test in the IVW methods was through use of Cochran Q statistic and for the MR-PRESSO method the global test.